EUS-Guided Pancreatic Diagnosis and Beyond

  • Shivakumar Vignesh H Lee Moffitt Cancer Center. Tampa FL, USA
  • Sarah E Hoffe H Lee Moffitt Cancer Center. Tampa FL, USA
  • Muhammad Wasif Saif Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital. New York, NY, USA
Keywords: Endosonography, Fiducial Markers, Pancreatic Neoplasms


The therapeutic ability of endoscopic ultrasound has expanded, especially in assisting with radiation planning for image guided radiation techniques such as stereotactic body radiation therapy. Endoscopic ultrasound enables precise placement of fiducial markers into pancreatic cancers to accurately delineate the position of the target lesion as it moves with respiration. The authors summarize the data presented at the 2011 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including Abstracts #302, #327, #176, #182, and #349.

Image: Dose painting of pancreas protocol CT scan (detail).


Download data is not yet available.


Vignesh S, Brugge W. Endoscopic diagnosis and treatment of pancreatic cysts. J Clin Gastroenterol 2008; 42:493-506. [PMID 18344889]

Romagnuolo J, Hoffman B, Vela S, Hawes R, Vignesh S. Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video). Gastrointest Endosc 2011; 73:52-63. [PMID 21184870]

Vignesh S, Jamidar P. EUS-guided pancreatogastrostomy and pancreatobulbostomy in patients with pancreatic-duct obstruction inaccessible to transpapillary endoscopic therapy: working our way to NOTES. Gastrointest Endosc 2007; 65:242-6. [PMID 17258982]

Sanders MK, Moser AJ, Khalid A, Fasanella KE, Zeh HJ, Burton S, McGrath K. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010; 71:1178-84. [PMID 20362284]

DiMaio CJ, Nagula S, Goodman KA, Ho AY, Markowitz AJ, Schattner MA, Gerdes H. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc 2010; 71:1204-10. [PMID 20598247]

Ammar T, Coté GA, Creach KM, Kohlmeier C, Parikh PJ, Azar RR. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc 2010; 71:630-3. [PMID 20189527]

Owens DJ, Savides TJ. Backloaded fiducial placement using a bone wax seal to facilitate EUS-guided fiducial placement. Gastrointest Endosc 2009; 69(2 Suppl.1):S253.

Pishvaian AC, Collins B, Gagnon G, Ahlawat S, Haddad NG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006; 64:412-7. [PMID 16923491]

Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010; 71:513-8. [PMID 20189509]

Van Dam J, Varadarajulu S, Jin Z, EUS 2008 Working Group. EUS 2008 Working Group document: evaluation of EUS-guided implantation therapy (with video). Gastrointest Endosc 2009; 69(2 Suppl):S49-53. [PMID 19179170]

Berzin TM, Majumder S, Mahadevan A, Pawa R, Ellsmere J, Sepe PS, et al. Comparison of EUS vs. surgery for placement of fiducials in patients with pancreatic cancer. Gastrointest Endosc 2010; 71:AB285.

Owens DJ, Savides TJ. EUS placement of metal fiducials by using a backloaded technique with bone wax seal. Gastrointest Endosc 2009; 69:972-3. [PMID 19152903]

Ghassemi S, Faigel DO. EUS-guided placement of fiducial markers using a 22-gauge needle. Gastrointest Endosc 2009; 69:AB337-8.

Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004; 58:1017-21. [PMID 15001240]

Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, et al. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys 2011; 79:151-7. [PMID 20421151]

Evans DB, Erickson BA, Ritch P. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol 2010; 17:2803-5. [PMID 20737218]

Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, et al. Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 2010; 17:2832-8. [PMID 20725860]

Vignesh S, Hoffe SE, Shridhar R, Klapman J, Barthel JS. The feasibility, safety, and technique of endoscopic ultrasound (EUS)-guided fiducial marker placement for stereotactic body radiation therapy (SBRT) in borderline resectable pancreatic cancer. J Clin Oncol 2011; 29(Suppl. 4):Abstract 327.

Chuong MD, Shridhar R, Patel M, Klapman J, Barthel JS, Vignesh S, et al. Neoadjuvant stereotactic body radiation therapy (SBRT) for borderline resectable pancreas cancer: Moffitt Cancer Center initial experience. J Clin Oncol 2011; 29(Suppl. 4):Abstract 302.

Strosberg JR, Cheema A, Kvols LK. Stage I nonfunctioning neuroendocrine tumors of the pancreas: surgery or surveillance? J Clin Oncol 2011; 29(Suppl. 4):Abstract 349.

Lee S, Cho JY. Use of endoscopic ultrasound scoring to estimate the malignant potential of branch duct type intraductal papillary-mucinous neoplasms of the pancreas. J Clin Oncol 2011; 29(Suppl. 4):Abstract 182.

Nguyen NQ, Lim K, Ruszkiewicz A. Preparation technique for cytologic study of EUS-guided FNA samples when onsite cytopathologist is absent: Cell block, smear, or both? J Clin Oncol 2011; 29(Suppl. 4):Abstract 176.

Dose painting of pancreas protocol CT scan (detail)
How to Cite
VigneshS., HoffeS., & SaifM. (2011). EUS-Guided Pancreatic Diagnosis and Beyond. JOP. Journal of the Pancreas, 12(2), 86-91.
Highlights from the “2011 ASCO Gastrointestinal Cancers Symposium”. San Francisco, CA, USA. January 20-22, 2011